Markets & Companies

Expert Interview: Jean-Luc Herbeaux, Hovione

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: GianMarco Negrisoli, Flamma

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: Peter Pekos, Dalton Pharma Services

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: Michael Quirmbach, CordenPharma

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Hydrogen – a Market with Potential

17.08.2020 -

Linde intends to further expand its hydrogen business by investing in electrolysis capacities and infrastructure.

Markets & Companies

Circular Economy

15.06.2020 -

The chemical industry is on the threshold of a new era – the age of circularity. We asked industry experts to share their opinions on this transformational topic.

Markets & Companies

Universal Influenza Vaccine Clearly a Strategic Goal

20.04.2020 - The Paul Ehrlich Institute is the German federal institute for vaccines and biomedicines. Klaus Cichutek has been president of the research institution and medical regulatory body...

Markets & Companies

Vaccine Research – an Ambitious and Important Venture

20.04.2020 - The worldwide spread of the corona virus shows once again that despite all technological progress, humanity is still exposed to health risks. The biotech and pharmaceutical...